Phase IV postmarketing surveillance study shows continued efficacy and safety of stempeucel® in patients with critical limb ischemia due to Buerger's disease

Pawan Kumar Gupta, Santanu Dutta, Sanjay Kala, Muralikrishna Nekkanti, Sanjay C. Desai, Subhendu S. Mahapatra, Anita Dhar, Radhakrishnan Raju, M. Rajkumar, Arunanshu Behera, P. Shivashankar, N. S. Raviraja, Pachaiyappan Viswanathan, Mithun Chandrashekar, Charan Thej, K. V. Prasanth, Jijy Abraham, Hema Boggarapu, K. Udaykumar

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase IV postmarketing surveillance study shows continued efficacy and safety of stempeucel® in patients with critical limb ischemia due to Buerger's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences